ÂÜÀòÂÒÂ×

Nicolas Barthelemy serves as a Member of the Board of Directors at Repligen Corporation since June 2014 and has held the position of Executive Chairman at Biocare Medical and Slingshot Biosciences since April 2018 and November 2021, respectively. Barthelemy is also a Senior Adviser at Warburg Pincus LLC since June 2020 and previously served as Chairman of the Board at NanoCellect Biomedical, Inc. until August 2024. Additional board positions include tenure at Twist Bioscience, 908 Devices, Fluidigm Corporation, and GENEWIZ, with the latter being acquired by Brooks Automation in October 2018. Barthelemy's prior experience includes serving as a Senior Advisor at Merieux Developpement from March 2016 to October 2018. Educational credentials include a Master of Sciences in Chemical Engineering from the University of California, Berkeley, as well as studies at Harvard Business School and Ecole Superieure de Physique et chimie de Paris (ESPCI).